Macrae Sandy
Transaction: 05/25/2026
SELL
Change
-12,613
Price
$0.17
Filing
05/27/2026
Type
SELL
Sangamo Therapeutics, Inc.
SGMO • Biotechnology
$0.07
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$28.83M
Growth
0.5%
Cash Flow
0/5
Trend
Negative
Evidence
Weak liquidity · 0.84Negative growth trendWeak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 14, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.07
Change0.00%
Shares Out389.62M
Market Cap$28.83M
Enterprise Value$20.58M
52W Range0.06 - 0.77
Beta1.30
P/E-0.23
P/S0.83
P/B-1.52
P/FCF-0.32
EV/Sales0.60
Price$0.07
Change0.00%
Shares Out389.62M
Market Cap$28.83M
Enterprise Value$20.58M
52W Range0.06 - 0.77
Beta1.30
P/E-0.23
P/S0.83
P/B-1.52
P/FCF-0.32
EV/Sales0.60
EV/EBITDA-0.20
EV/FCF-0.23
Earnings Yield-427.76%
FCF Yield-313.74%
Dividend Yield0.00%
Gross Margin80.78%
Oper. Margin-2.73%
Profit Margin-3.11%
Debt/Eq-1.88
Current Ratio0.84
Quick Ratio0.84
Revenue 5Y0.48%
Target$7.25
Target Upside9697.30%
Target Median$4.00
Target Range2.00 - 19.00
Volume28.50M
Avg Volume10.60M
EPS Surprise-0.09
Investment DNA
How strong this company looks for long-term investors
34
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
32/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
79/100
Why this score▼
Weak liquidity · 0.84Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 14 analyst votes · 2026-09-05
68/100
Neutral
Bullish
6
Hold
7
Bearish
1
Price Target
2026-07-02
Low
$2.00
Mean
$7.25
Median
$4.00
High
$19.00
Insider Transactions
Recent executive and insider activity
⚠ 1 high-volume insider sell detected
Willoughby Scott B.
Transaction: 05/25/2026
SELL
Change
-4,036
Price
$0.17
Filing
05/27/2026
Type
SELL
Dubois-Stringfellow Nathalie
Transaction: 05/25/2026
SELL
Change
-4,036
Price
$0.17
Filing
05/27/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Macrae Sandy | SELL | -12,613 | $0.17 | 05/25/2026 | 05/27/2026 |
| Willoughby Scott B. | SELL | -4,036 | $0.17 | 05/25/2026 | 05/27/2026 |
| Dubois-Stringfellow Nathalie | SELL | -4,036 | $0.17 | 05/25/2026 | 05/27/2026 |
| Jain Nikunj | SELL | -1,919 | $0.17 | 05/25/2026 | 05/27/2026 |
| Davis Gregory D | SELL | -1,630 | $0.17 | 05/25/2026 | 05/27/2026 |
| Davis Gregory D | SELL | -69,827 | $0.25 | 04/22/2026 | 04/23/2026 |
| Dubois-Stringfellow Nathalie | SELL | -345,942 | $0.26 | 04/21/2026 | 04/23/2026 |
| Willoughby Scott B. | BUY | +800,000 | $0.26 | 04/01/2026 | 04/03/2026 |
| Macrae Sandy | BUY | +2,500,000 | $0.26 | 04/01/2026 | 04/03/2026 |
| Davis Gregory D | BUY | +225,000 | $0.26 | 04/01/2026 | 04/03/2026 |
| Jain Nikunj | BUY | +225,000 | $0.26 | 04/01/2026 | 04/03/2026 |
| Dubois-Stringfellow Nathalie | BUY | +800,000 | $0.26 | 04/01/2026 | 04/03/2026 |
| Davis Gregory D | SELL | -5,119 | $0.47 | 02/25/2026 | 02/26/2026 |
| Jain Nikunj | SELL | -5,119 | $0.47 | 02/25/2026 | 02/26/2026 |
| Willoughby Scott B. | SELL | -12,354 | $0.47 | 02/25/2026 | 02/26/2026 |
| Macrae Sandy | SELL | -33,637 | $0.47 | 02/25/2026 | 02/26/2026 |
| Dubois-Stringfellow Nathalie | SELL | -12,354 | $0.47 | 02/25/2026 | 02/26/2026 |
| Davis Gregory D | SELL | -832 | $0.47 | 02/24/2026 | 02/26/2026 |
| Jain Nikunj | SELL | -666 | $0.47 | 02/24/2026 | 02/26/2026 |
| Willoughby Scott B. | SELL | -1,650 | $0.47 | 02/24/2026 | 02/26/2026 |